HFA Premium Access

Budget impact of iv iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany

Congress Presentation

About the speaker

Mrs Ulrike Theidel

Xcenda GmbH, Hannover (Germany)
1 presentation
0 follower

23 more presentations in this session

Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA trial): 10 years follow-up.

Speaker: Associate Professor D. D'Amario (Novara, IT)


Ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta-analysis of randomized, double-blinded clinical trials

Speaker: Professor V. Mitrovic (Nauheim, DE)


Ivabradine reduces early readmission after hospitalization for worsening heart failure: a post-hoc analysis of SHIFT

Speaker: Professor M. Komajda (Paris, FR)


Favorable long-term mortality profile in nyha iii/iv patients treated with cardiac contractility modulation (CCM)

Speaker: Professor D. Burkhoff (New York, US)


First transcatheter intracardiac shunt device to reduce left atrial pressure in heart failure with preserved ejection fraction; the REDUCE elevated levt atrial pressure in patients with heart failure

Speaker: Professor G. Hasenfuss (Goettingen, DE)


Access the full session

Clinical Forum - Sat. 21 May 08:30 - Sun. 22 May 18:00

Speakers: Mrs U. Theidel, Associate Professor D. D'Amario, Professor V. Mitrovic, Professor M. Komajda, Professor D. Burkhoff...

About the event



21 May - 24 May 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb